603 related articles for article (PubMed ID: 25846811)
1. Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells.
Kawashima I; Mitsumori T; Nozaki Y; Yamamoto T; Shobu-Sueki Y; Nakajima K; Kirito K
Exp Hematol; 2015 Jul; 43(7):524-33.e1. PubMed ID: 25846811
[TBL] [Abstract][Full Text] [Related]
2. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
3. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
[TBL] [Abstract][Full Text] [Related]
5. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
6. LKB1/AMPK inhibits TGF-β1 production and the TGF-β signaling pathway in breast cancer cells.
Li NS; Zou JR; Lin H; Ke R; He XL; Xiao L; Huang D; Luo L; Lv N; Luo Z
Tumour Biol; 2016 Jun; 37(6):8249-58. PubMed ID: 26718214
[TBL] [Abstract][Full Text] [Related]
7. PD98059 and U0126 activate AMP-activated protein kinase by increasing the cellular AMP:ATP ratio and not via inhibition of the MAP kinase pathway.
Dokladda K; Green KA; Pan DA; Hardie DG
FEBS Lett; 2005 Jan; 579(1):236-40. PubMed ID: 15620719
[TBL] [Abstract][Full Text] [Related]
8. Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways.
Do MT; Kim HG; Khanal T; Choi JH; Kim DH; Jeong TC; Jeong HG
Toxicol Appl Pharmacol; 2013 Sep; 271(2):229-38. PubMed ID: 23707609
[TBL] [Abstract][Full Text] [Related]
9. ERK/MAPK activation involves hypoxia-induced MGr1-Ag/37LRP expression and contributes to apoptosis resistance in gastric cancer.
Liu L; Zhang H; Sun L; Gao Y; Jin H; Liang S; Wang Y; Dong M; Shi Y; Li Z; Fan D
Int J Cancer; 2010 Aug; 127(4):820-9. PubMed ID: 19998339
[TBL] [Abstract][Full Text] [Related]
10. AMP-activated protein kinase antagonizes pro-apoptotic extracellular signal-regulated kinase activation by inducing dual-specificity protein phosphatases in response to glucose deprivation in HCT116 carcinoma.
Kim MJ; Park IJ; Yun H; Kang I; Choe W; Kim SS; Ha J
J Biol Chem; 2010 May; 285(19):14617-27. PubMed ID: 20220132
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
[TBL] [Abstract][Full Text] [Related]
12. Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells.
Hwang JT; Kim YM; Surh YJ; Baik HW; Lee SK; Ha J; Park OJ
Cancer Res; 2006 Oct; 66(20):10057-63. PubMed ID: 17047069
[TBL] [Abstract][Full Text] [Related]
13. Liver Kinase B1/AMP-Activated Protein Kinase Pathway Activation Attenuated the Progression of Endotoxemia in the Diabetic Mice.
Yang Y; Dong R; Hu D; Chen Z; Fu M; Wang DW; Xu X; Tu L
Cell Physiol Biochem; 2017; 42(2):761-779. PubMed ID: 28628912
[TBL] [Abstract][Full Text] [Related]
14. The adaptor protein NTAL enhances proximal signaling and potentiates corticosteroid-induced apoptosis in T-ALL.
Svojgr K; Kalina T; Kanderova V; Skopcova T; Brdicka T; Zuna J
Exp Hematol; 2012 May; 40(5):379-85. PubMed ID: 22269118
[TBL] [Abstract][Full Text] [Related]
15. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
[TBL] [Abstract][Full Text] [Related]
16. Regulation of death induction and chemosensitizing action of 3-bromopyruvate in myeloid leukemia cells: energy depletion, oxidative stress, and protein kinase activity modulation.
Calviño E; Estañ MC; Sánchez-Martín C; Brea R; de Blas E; Boyano-Adánez Mdel C; Rial E; Aller P
J Pharmacol Exp Ther; 2014 Feb; 348(2):324-35. PubMed ID: 24307199
[TBL] [Abstract][Full Text] [Related]
17. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells.
Sanli T; Rashid A; Liu C; Harding S; Bristow RG; Cutz JC; Singh G; Wright J; Tsakiridis T
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):221-9. PubMed ID: 20615625
[TBL] [Abstract][Full Text] [Related]
18. AMP as a low-energy charge signal autonomously initiates assembly of AXIN-AMPK-LKB1 complex for AMPK activation.
Zhang YL; Guo H; Zhang CS; Lin SY; Yin Z; Peng Y; Luo H; Shi Y; Lian G; Zhang C; Li M; Ye Z; Ye J; Han J; Li P; Wu JW; Lin SC
Cell Metab; 2013 Oct; 18(4):546-55. PubMed ID: 24093678
[TBL] [Abstract][Full Text] [Related]
19. An investigation of the effects of the MEK inhibitor U0126 on apoptosis in acute leukemia.
James JA; Smith MA; Court EL; Yip C; Ching Y; Willson C; Smith JG
Hematol J; 2003; 4(6):427-32. PubMed ID: 14671615
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F
Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
